9 reports

Global Market Study on Sleep Aid Devices: Rise in Awareness About Sleep Related Disorders Fueling Revenue Growth ##.

  • OTC
  • Sleep Aid
  • Forecast
  • Market Size
  • GLOBAL SLEEPING AID MARKET BY PRODUCTS: MARKET SHARE 2016-2021 (%)
  • RISING PREVALENCE OF OSA

These multipurpose products aid in the treatment of sleep disorders.

  • Sleep Aid
  • Cadwell Laboratories, Inc.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • Sleep Aid Value Sales (USD million rsp) and Spend per Capita (USD) by Selected Market 2016
  • Germany: Sleep Aid Value Sales (USD million rsp) 2011/2016 and % CAGR 2011- 2016 by Brand

As Otsuka reframes the positioning of the Nature Made brand as one around dietary supplements, this line is steadily moving out of the sleep aid space.

  • Sleep Aid
  • World
  • Demand
  • Bayer AG
  • Pfizer Inc.
  • 5.2.2.1 EROSION IN BRANDED PRESCRIPTION SLEEP AID SALES DUE TO GROWING ADOPTION OF GENERICS
  • U.S.: OVER-THE-COUNTER (OTC) SLEEP AIDS MARKET SIZE FOR INSOMNIA, BY TYPE, 2013-2021 (USD MILLION)

Furthermore, publicity regarding the side-effects of the prescription sleep aids has also steered the patients towards OTC sleep aid options.

  • Sleep Aid
  • United States
  • Company
  • Market Size
  • Merck & Co., Inc.
  • Target

CLINICAL TRIALS BY PHASE IN E## COUNTRIES SLEEP DISORDERS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* SLEEP DISORDERS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* SLEEP DISORDERS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* Coun

  • Clinical Trial
  • Neurology
  • Sleep Aid
  • World
  • Takeda Pharmaceutical Company Limited

Adverse effects of sleep aid medication ##. ##. ##. ##.

  • OTC
  • Sleep Aid
  • APAC
  • World
  • Market Size

On the basis of sleep disorder, the sleep aids market comprises insomnia, sleep apnea, restless legs syndrome, narcolepsy and sleep walking.

  • OTC
  • Sleep Aid
  • World
  • Market Size
  • SEP 26, 2018: ZELDA THERAPEUTICS: FIRST PATIENT DOSED IN ZELDA INSOMNIA TRIAL

The Aytu BioScience sales force begins promoting ZolpiMist to U. S. clinicians today in the domestic $##. ## billion nonbenzodiazepine prescription sleep aid market.

  • Pharmaceutical
  • Sleep Aid
  • Therapy
  • United States
  • Product Initiative
  • NRT SMOKING CESSATION AIDS IN FINLAND - CATEGORY ANALYSIS

More Sophisticated Products Expected To Be Launched In addition to higher-dose products, it is expected that more innovative sleep aid products will be introduced.

  • OTC
  • Sleep Aid
  • Finland
  • Demand